Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Triple Negative Breast Neoplasms
×
zanidatamab
×
Clear all
Filters
3
NCT01042379
2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT05868226
2025-04-04
PRE-I-SPY-PI
QuantumLeap Healthcare Collaborative
Phase 1
Recruiting
124 enrolled